retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & hormone receptor drug Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

















.jpg?w=8688&max-h=5792&fit=crop&auto=format)




